Next Article in Journal
Focused Ultrasound-Mediated Disruption of the Blood–Brain Barrier for AAV9 Delivery in a Mouse Model of Huntington’s Disease
Previous Article in Journal
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Previous Article in Special Issue
Development of 5-Fluorouracil/pH-Responsive Adjuvant-Embedded Extracellular Vesicles for Targeting αvβ3 Integrin Receptors in Tumors
 
 
Review

Article Versions Notes

Pharmaceutics 2024, 16(6), 709; https://doi.org/10.3390/pharmaceutics16060709
Action Date Notes Link
article pdf uploaded. 24 May 2024 13:58 CEST Version of Record https://www.mdpi.com/1999-4923/16/6/709/pdf-vor
article xml file uploaded 29 May 2024 09:54 CEST Original file -
article xml uploaded. 29 May 2024 09:54 CEST Update https://www.mdpi.com/1999-4923/16/6/709/xml
article pdf uploaded. 29 May 2024 09:54 CEST Updated version of record https://www.mdpi.com/1999-4923/16/6/709/pdf
article html file updated 29 May 2024 09:56 CEST Original file https://www.mdpi.com/1999-4923/16/6/709/html
Back to TopTop